Behzod Tashbayev

485 total citations
18 papers, 326 citations indexed

About

Behzod Tashbayev is a scholar working on Public Health, Environmental and Occupational Health, Dermatology and Immunology and Allergy. According to data from OpenAlex, Behzod Tashbayev has authored 18 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Public Health, Environmental and Occupational Health, 8 papers in Dermatology and 7 papers in Immunology and Allergy. Recurrent topics in Behzod Tashbayev's work include Ocular Surface and Contact Lens (18 papers), Allergic Rhinitis and Sensitization (7 papers) and Salivary Gland Disorders and Functions (6 papers). Behzod Tashbayev is often cited by papers focused on Ocular Surface and Contact Lens (18 papers), Allergic Rhinitis and Sensitization (7 papers) and Salivary Gland Disorders and Functions (6 papers). Behzod Tashbayev collaborates with scholars based in Norway, United States and Sweden. Behzod Tashbayev's co-authors include Tor Paaske Utheim, Øygunn Aass Utheim, Xiangjun Chen, Janicke Liaaen Jensen, Mazyar Yazdani, Reiko Arita, Øyvind Palm, Lara A. Aqrawi, Darlene A. Dartt and Lene Hystad Hove and has published in prestigious journals such as PLoS ONE, Scientific Reports and Investigative Ophthalmology & Visual Science.

In The Last Decade

Behzod Tashbayev

18 papers receiving 322 citations

Peers

Behzod Tashbayev
Michelle Hessen United States
Andrew J. McClellan United States
Kenneth A. Beckman United States
Steven L. Maskin United States
Dorothy Tolls United States
M. Vallabhajosyula United States
Michelle Hessen United States
Behzod Tashbayev
Citations per year, relative to Behzod Tashbayev Behzod Tashbayev (= 1×) peers Michelle Hessen

Countries citing papers authored by Behzod Tashbayev

Since Specialization
Citations

This map shows the geographic impact of Behzod Tashbayev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Behzod Tashbayev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Behzod Tashbayev more than expected).

Fields of papers citing papers by Behzod Tashbayev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Behzod Tashbayev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Behzod Tashbayev. The network helps show where Behzod Tashbayev may publish in the future.

Co-authorship network of co-authors of Behzod Tashbayev

This figure shows the co-authorship network connecting the top 25 collaborators of Behzod Tashbayev. A scholar is included among the top collaborators of Behzod Tashbayev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Behzod Tashbayev. Behzod Tashbayev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tashbayev, Behzod, Reza A. Badian, Xiangjun Chen, et al.. (2025). Comparison of non-invasive and fluorescein tear film break-up time in a 65-year-old Norwegian population: a cross-sectional study. BMJ Open. 15(4). e090305–e090305. 1 indexed citations
2.
Tashbayev, Behzod, Katja Benedikte Prestø Elgstøen, Helge Rootwelt, et al.. (2023). Tear and Saliva Metabolomics in Evaporative Dry Eye Disease in Females. Metabolites. 13(11). 1125–1125. 9 indexed citations
3.
Tashbayev, Behzod, Xiangjun Chen, & Tor Paaske Utheim. (2023). Chalazion Treatment: A Concise Review of Clinical Trials. Current Eye Research. 49(2). 109–118. 2 indexed citations
4.
Tashbayev, Behzod, Reza A. Badian, Xiangjun Chen, et al.. (2022). The relationship between ocular and oral dryness in a cohort from the 65-year-old population in Norway. Scientific Reports. 12(1). 9805–9805. 4 indexed citations
5.
Chen, Xiangjun, Reza A. Badian, Behzod Tashbayev, et al.. (2022). Morphology of Meibomian Glands in a 65-Year-Old Norwegian Population without Dry Eye Disease. Journal of Clinical Medicine. 11(3). 527–527. 4 indexed citations
6.
Badian, Reza A., Tor Paaske Utheim, Øygunn Aass Utheim, et al.. (2020). Sex and age differences in symptoms and signs of dry eye disease in a Norwegian cohort of patients. The Ocular Surface. 19. 68–73. 20 indexed citations
7.
Tashbayev, Behzod, et al.. (2020). Intense pulsed light treatment in meibomian gland dysfunction: A concise review. The Ocular Surface. 18(4). 583–594. 59 indexed citations
8.
Tashbayev, Behzod, T. Garen, Øyvind Palm, et al.. (2020). Patients with non-Sjögren’s sicca report poorer general and oral health-related quality of life than patients with Sjögren’s syndrome: a cross-sectional study. Scientific Reports. 10(1). 2063–2063. 20 indexed citations
9.
Tashbayev, Behzod, Tor Paaske Utheim, Øygunn Aass Utheim, et al.. (2020). Utility of Tear Osmolarity Measurement in Diagnosis of Dry Eye Disease. Scientific Reports. 10(1). 5542–5542. 36 indexed citations
10.
Yazdani, Mazyar, Xiangjun Chen, Behzod Tashbayev, et al.. (2019). Evaluation of the Ocular Surface Disease Index Questionnaire as a Discriminative Test for Clinical Findings in Dry Eye Disease Patients. Current Eye Research. 44(9). 941–947. 12 indexed citations
11.
Chen, Xiangjun, Lara A. Aqrawi, Tor Paaske Utheim, et al.. (2019). Elevated cytokine levels in tears and saliva of patients with primary Sjögren’s syndrome correlate with clinical ocular and oral manifestations. Scientific Reports. 9(1). 7319–7319. 68 indexed citations
12.
Aqrawi, Lara A., Xiangjun Chen, Janicke Liaaen Jensen, et al.. (2018). Severity of clinical dry eye manifestations influences protein expression in tear fluid of patients with primary Sjögren’s syndrome. PLoS ONE. 13(10). e0205762–e0205762. 19 indexed citations
13.
Utheim, Øygunn Aass, Xiangjun Chen, Snorri Ólafsson, et al.. (2018). Changes in Signs and Symptoms of Dry Eye Disease after using 0.1% or 0.05% Emulsions of Cyclosporine A Eye Drops. Investigative Ophthalmology & Visual Science. 59(9). 912–912. 1 indexed citations
14.
Landsend, Erlend Christoffer Sommer, Hilde R. Pedersen, Øygunn Aass Utheim, et al.. (2018). Meibomian gland dysfunction and keratopathy are associated with dry eye disease in aniridia. British Journal of Ophthalmology. 103(1). 119–124. 18 indexed citations
15.
Yazdani, Mazyar, Xiangjun Chen, Behzod Tashbayev, et al.. (2018). Tear Production Levels and Dry Eye Disease Severity in a Large Norwegian Cohort. Current Eye Research. 43(12). 1465–1470. 8 indexed citations
16.
Chen, Xiangjun, Øygunn Aass Utheim, Jiaxin Xiao, et al.. (2017). Meibomian gland features in a Norwegian cohort of patients with primary Sjögren´s syndrome. PLoS ONE. 12(9). e0184284–e0184284. 21 indexed citations
17.
Tashbayev, Behzod, Shermin Rusthen, Alix Young, et al.. (2017). Interdisciplinary, Comprehensive Oral and Ocular Evaluation of Patients with Primary Sjögren’s Syndrome. Scientific Reports. 7(1). 10761–10761. 23 indexed citations
18.
Eidet, Jon Roger, Behzod Tashbayev, Sten Ræder, et al.. (2016). Pollen count compared with severity of symptoms and signs of dry eye disease in Norway. Acta Ophthalmologica. 94(S256). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026